Evidence-Based Complementary and Alternative Medicine / 2015 / Article / Tab 1

Research Article

Gastrodin Reduces Blood Pressure by Intervening with RAAS and PPARγ in SHRs

Table 1

Cardiac function (means ± SEM).

IVS; d (mm)IVS; s (mm)LVID; d (mm)LVID; s (mm)LVPW; d (mm)LVPW; s (mm)EF (%)

WKY1.29 ± 0.072.21 ± 0.296.35 ± 0.433.77 ± 0.581.64 ± 0.152.48 ± 0.1669.95 ± 8.40
SHR1.70 ± 0.182.33 ± 0.376.24 ± 0.804.42 ± 1.232.02 ± 0.262.41 ± 0.4755.16 ± 17.32
GAS1.53 ± 0.242.09 ± 0.226.73 ± 0.424.88 ± 0.491.87 ± 0.252.35 ± 0.2151.95 ± 7.87

After 4-week treatment, there was no difference in cardiac function among the three groups.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.